205 related articles for article (PubMed ID: 15293888)
1. Serum levels of prostate-specific antigen and androgens after nasal administration of a gonadotropin releasing hormone-agonist in hirsute women.
Kocak M; Tarcan A; Beydilli G; Koç S; Haberal A
Gynecol Endocrinol; 2004 Apr; 18(4):179-85. PubMed ID: 15293888
[TBL] [Abstract][Full Text] [Related]
2. High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
Guzelmeric K; Seker N; Unal O; Turan C
Gynecol Endocrinol; 2004 Oct; 19(4):190-5. PubMed ID: 15724801
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
Andreyko JL; Monroe SE; Jaffe RB
J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
[TBL] [Abstract][Full Text] [Related]
4. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
[TBL] [Abstract][Full Text] [Related]
5. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
[TBL] [Abstract][Full Text] [Related]
6. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills.
Escobar-Morreale HF; Avila S; Sancho J
J Clin Endocrinol Metab; 2000 Jul; 85(7):2488-92. PubMed ID: 10902798
[TBL] [Abstract][Full Text] [Related]
7. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
Lakryc EM; Motta EL; Soares JM; Haidar MA; de Lima GR; Baracat EC
Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020
[TBL] [Abstract][Full Text] [Related]
8. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function.
Escobar-Morreale HF; Serrano-Gotarredona J; Avila S; Villar-Palasí J; Varela C; Sancho J
J Clin Endocrinol Metab; 1998 Jul; 83(7):2580-4. PubMed ID: 9661648
[TBL] [Abstract][Full Text] [Related]
9. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in women with idiopathic hirsutism.
Gregoriou O; Kouskouni E; Bakas P; Konidaris S; Papadias K; Kalovidouris A; Creatsas G
Gynecol Endocrinol; 2000 Oct; 14(5):364-8. PubMed ID: 11109975
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
13. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
Frölich M; Lachinsky N; Moolenaar AJ
Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
[TBL] [Abstract][Full Text] [Related]
15. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
Vural B; Ozkan S; Bodur H
J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
[TBL] [Abstract][Full Text] [Related]
16. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of prostatic specific antigen in hirsute women.
Güllü S; Emral R; Asik M; Cesur M; Tonyukuk V
J Endocrinol Invest; 2003 Dec; 26(12):1198-202. PubMed ID: 15055472
[TBL] [Abstract][Full Text] [Related]
18. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
19. Androsterone sulfate: physiology and clinical significance in hirsute women.
Zwicker H; Rittmaster RS
J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen in female serum, a potential new marker of androgen excess.
Melegos DN; Yu H; Ashok M; Wang C; Stanczyk F; Diamandis EP
J Clin Endocrinol Metab; 1997 Mar; 82(3):777-80. PubMed ID: 9062481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
